Clinical Trial Update: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update for Pegol-Sihematide in anemia associated with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Pegol-Sihematide (Pegol-Sihematide)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Kidney Diseases | Phase 3 | Status: COMPLETED